Contract Manufacturing: Pharma’s New Growth Pill
Domestic contract development and manufacturing organisations are raking it in, thanks to India’s emergence as a pharma R&D hub and China’s supply chain issues.
Domestic contract development and manufacturing organisations are raking it in, thanks to India’s emergence as a pharma R&D hub and China’s supply chain issues.
Under Satyanarayana Chava, the company has entered cutting-edge areas such as gene therapy and rare diseases.
India’s life sciences R&D is undergoing a sea change. Given the huge risks and investments involved, can India taste success in innovative medicine, therapy and diagnostic tools?